relisting 11th feb, page-6

Well, what a surprise! Nice day on re-listing.

Basically the news comes down to this:

BOS needs cash, RGM needs cash and a vehicle to list on the ASX. A key condition to the T/O is a cap raising of a minimum $4 million. That's fine, BOS SH's will have a chance to participate.

The real short-term upside rests with the CBTE deal in the U.S. If GL Biochem proceed with the merger over there and CBTE keep their listing on the NASDAQ then the CBTE SP will fly and BOS will do well out of it also.

The valuation in the Independent Expert's report values CBTE shares at around 30 cents which is where they are at present. The finalising of the GL Biochem merger should see CBTE shares pass $1.00 IMO.

Regardless, the takeover of RGM is a good thing anyway, so BOS is looking a lot better now.